Pacer Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History
Pacer Advisors, Inc.
- $41.8 Billion
- Q3 2024
A detailed history of Pacer Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,589,648 shares of COLL stock, worth $75.5 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,589,648
Previous 3,408,369
24.02%
Holding current value
$75.5 Million
Previous $110 Million
8.83%
% of portfolio
0.24%
Previous 0.28%
Shares
13 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$169 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.8 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$68.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.3 Million0.1% of portfolio
-
Invesco Ltd. Atlanta, GA1.49MShares$43.3 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $995M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...